We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
+$133M
Cap. Flow
+$228M
Cap. Flow %
6.44%
Top 10 Hldgs %
31.71%
Holding
123
New
40
Increased
24
Reduced
23
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$71.8M
2
ABBV icon
AbbVie
ABBV
+$63.8M
3
CI icon
Cigna
CI
+$62.3M
4
PBYI icon
Puma Biotechnology
PBYI
+$49.5M
5
UNH icon
UnitedHealth
UNH
+$44.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$99.2M
2
META icon
Meta Platforms (Facebook)
META
+$73.1M
3
BAX icon
Baxter International
BAX
+$70M
4
NOW icon
ServiceNow
NOW
+$67.7M
5
V icon
Visa
V
+$65.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.7%
2 Technology 6.07%
3 Energy 6.01%
4 Industrials 3.89%
5 Communication Services 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
26
DELISTED
Hologic
HOLX
$42.3M 1.19%
+1,053,787
New +$40.7M
DISH
27
DELISTED
DISH Network Corp.
DISH
$41.8M 1.18%
722,103
-826,534
-53% -$47.2M
PYPL icon
28
PayPal
PYPL
$49.5B
$41.4M 1.17%
+1,049,130
New +$42.2M
GOOGL icon
29
Alphabet (Google) Class A
GOOGL
$3.91T
$40.8M 1.15%
1,028,860
+102,160
+11% +$4.08M
WFT
30
DELISTED
Weatherford International plc
WFT
$39.3M 1.11%
+7,884,566
New +$41.2M
PCRX icon
31
Pacira BioSciences
PCRX
$1.02B
$37.5M 1.06%
+1,160,975
New +$38.7M
HRTX icon
32
Heron Therapeutics
HRTX
$86.3M
$35.8M 1.01%
2,733,277
-656,975
-19% -$10.3M
PBYI icon
33
Puma Biotechnology
PBYI
$406M
$35.1M 0.99%
+1,143,688
New +$49.5M
META icon
34
Meta Platforms (Facebook)
META
$1.51T
$34.1M 0.96%
296,004
-595,585
-67% -$73.1M
SPNC
35
DELISTED
Spectranetics Corp
SPNC
$33.5M 0.94%
1,365,945
+1,197,900
+713% +$28.2M
RICE
36
DELISTED
Rice Energy Inc.
RICE
$33M 0.93%
1,544,162
+339,017
+28% +$8.08M
PANW icon
37
Palo Alto Networks
PANW
$264B
$32.3M 0.91%
1,547,472
-1,468,344
-49% -$35.2M
IBB icon
38
iShares Biotechnology ETF
IBB
$9.31B
$30.1M 0.85%
+340,197
New +$31M
XBI icon
39
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$29.9M 0.84%
+505,750
New +$31.2M
TSRO
40
PUT
DELISTED
TESARO, Inc.
TSRO
$29.7M 0.84%
+221,100
New +$27.9M
DXJ icon
41
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
$29.7M 0.84%
+599,921
New +$28.2M
MRVL icon
42
Marvell Technology
MRVL
$174B
$28.4M 0.8%
+2,045,950
New +$27.9M
DVN icon
43
Devon Energy
DVN
$51.9B
$27.1M 0.76%
592,379
-175,582
-23% -$7.75M
CRUS icon
44
Cirrus Logic
CRUS
$6.74B
$27M 0.76%
478,077
-74,211
-13% -$4.11M
STLD icon
45
Steel Dynamics
STLD
$35.6B
$25.2M 0.71%
+709,389
New +$22.3M
VISN
46
Vistance Networks Inc
VISN
$2.66B
$25M 0.71%
672,767
-600,535
-47% -$20.5M
MNK
47
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$25M 0.7%
+501,400
New +$29.5M
IONS icon
48
Ionis Pharmaceuticals
IONS
$9.35B
$22.5M 0.63%
470,534
-179,182
-28% -$7.09M
BPMC
49
DELISTED
Blueprint Medicines
BPMC
$22.4M 0.63%
799,951
+246,866
+45% +$7.44M
COLL icon
50
Collegium Pharmaceutical
COLL
$1.14B
$22.1M 0.62%
1,418,141
+1,015,695
+252% +$16.9M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2016 Portfolio in Review

As of Q4 2016, PFM Health Sciences held 123 positions worth $3.55B, up 3.9% from $3.42B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences deployed $228M of net new capital in Q4 2016, opening 40 new positions and adding to 24 existing holdings. Its largest new stake was Elevance Health: 536,457 shares worth $77.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $73.1M trimmed.

  • PFM Health Sciences's largest Q4 2016 buy was Elevance Health: 536,457 shares worth $77.1M.
  • PFM Health Sciences added most to AbbVie in Q4 2016, an estimated $63.8M increase.
  • PFM Health Sciences's biggest Q4 2016 reduction was Meta Platforms (Facebook), cutting an estimated $73.1M.
  • PFM Health Sciences fully exited Apple in Q4 2016, selling an estimated $99.2M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.55B portfolio in Q4 2016.
  • PFM Health Sciences opened 40 new positions and closed 30 in Q4 2016.
  • PFM Health Sciences's portfolio value rose 3.9% quarter-over-quarter to $3.55B.

Based on PFM Health Sciences's 13F filing for Q4 2016, filed 14 Feb 2017.